{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:03Z","timestamp":1788815283111,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ21H060008"],"award-info":[{"award-number":["LQ21H060008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY24H060003"],"award-info":[{"award-number":["LY24H060003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172459"],"award-info":[{"award-number":["82172459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102598"],"award-info":[{"award-number":["82102598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118327","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:30:27Z","timestamp":1786059027000},"page":"118327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["2\u2032-O-Galloylhyperin attenuates osteoclastogenesis and estrogen-deficiency osteoporosis by targeting MLK3-mediated NF-\u03baB signaling"],"prefix":"10.1016","volume":"253","author":[{"given":"Gaolu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisheng","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118327_b0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10169","key":"10.1016\/j.bcp.2026.118327_b0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2026.118327_b0015","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7753","key":"10.1016\/j.bcp.2026.118327_b0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2026.118327_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bcp.2026.118327_b0030","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"McDonald","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2026.118327_b0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00774-015-0683-1","article-title":"The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts","volume":"34","author":"Thirukonda","year":"2016","journal-title":"J. Bone Miner. Metab."},{"issue":"8","key":"10.1016\/j.bcp.2026.118327_b0040","doi-asserted-by":"crossref","DOI":"10.1242\/dev.199908","article-title":"The origins and roles of osteoclasts in bone development, homeostasis and repair","volume":"149","author":"Yahara","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.bcp.2026.118327_b0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fendo.2015.00041","article-title":"Coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface?","volume":"6","author":"Sims","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bcp.2026.118327_b0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fmed.2017.00234","article-title":"Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review","volume":"4","author":"Bi","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118327_b0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bcp.2026.118327_b0060","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bcp.2026.118327_b0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"issue":"6","key":"10.1016\/j.bcp.2026.118327_b0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"12","key":"10.1016\/j.bcp.2026.118327_b0075","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/jbmr.2584","article-title":"Alternative NF-\u03baB regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms","volume":"30","author":"Zeng","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bcp.2026.118327_b0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5483\/BMBRep.2021.54.9.070","article-title":"IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-\u03baB\/NFATc1 signaling","volume":"54","author":"Kim","year":"2021","journal-title":"BMB Rep."},{"key":"10.1016\/j.bcp.2026.118327_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.693777","article-title":"ZhiJingSan inhibits osteoclastogenesis via regulating RANKL\/NF-\u03baB signaling pathway and ameliorates bone erosion in collagen-induced mouse arthritis","volume":"12","author":"Ling","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118327_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110137","article-title":"Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation","volume":"87","author":"Zhuang","year":"2021","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2026.118327_b0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/me.2007-0237","article-title":"NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"22","author":"Kim","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118327_b0100","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.febslet.2009.06.047","article-title":"Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation","volume":"583","author":"Song","year":"2009","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.118327_b0105","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/jcp.26084","article-title":"Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades","volume":"233","author":"Song","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118327_b0110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/jbmr.3031","article-title":"TRAF6 mediates suppression of osteoclastogenesis and prevention of ovariectomy-induced bone loss by a novel prenylflavonoid","volume":"32","author":"Tan","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118327_b0115","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbrc.2018.11.201","article-title":"Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-\u03baB and MAPK signaling pathways","volume":"508","author":"Xu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2026.118327_b0120","doi-asserted-by":"crossref","first-page":"e2711","DOI":"10.1210\/clinem\/dgae732","article-title":"2'-O-Galloylhyperin prevents tissue remodeling in thyroid eye disease: prospects as a thyrotropin receptor antagonist","volume":"110","author":"Guo","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2026.118327_b0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fphar.2018.00679","article-title":"2'-O-Galloylhyperin Isolated from Pyrola incarnata Fisch. attenuates LPS-induced inflammatory response by activation of SIRT1\/Nrf2 and inhibition of the NF-\u03baB pathways in vitro and vivo","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118327_b0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fct.2017.02.016","article-title":"Hepatoprotective effect of 2'-O-galloylhyperin against oxidative stress-induced liver damage through induction of Nrf2\/ARE-mediated antioxidant pathway","volume":"102","author":"Wang","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2026.118327_b0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2019.02.029","article-title":"2'O-galloylhyperin attenuates LPS-induced acute lung injury via up-regulation antioxidation and inhibition of inflammatory responses in vivo","volume":"304","author":"Zhang","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.bcp.2026.118327_b0140","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.7150\/thno.30206","article-title":"Pseurotin a inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.bcp.2026.118327_b0145","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118327_b0150","first-page":"2088","article-title":"RelA\/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice","volume":"118","author":"Vaira","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2026.118327_b0155","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/s41467-018-05244-y","article-title":"Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss","volume":"9","author":"Xiong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118327_b0160","article-title":"Isoliensinine suppresses osteoclast formation through NF-\u03baB signaling pathways and relieves ovariectomy-induced bone loss","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118327_b0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s10020-024-01031-2","article-title":"Denatonium inhibits RANKL-induced osteoclast differentiation and rescues the osteoporotic phenotype by blocking p65 signaling pathway","volume":"30","author":"Lee","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2026.118327_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41413-019-0079-2","article-title":"L-Plastin deficiency produces increased trabecular bone due to attenuation of sealing ring formation and osteoclast dysfunction","volume":"8","author":"Chellaiah","year":"2020","journal-title":"Bone Res."},{"key":"10.1016\/j.bcp.2026.118327_b0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75610","article-title":"Nanoscale architecture and coordination of actin cores within the sealing zone of human osteoclasts","volume":"11","author":"Portes","year":"2022","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.bcp.2026.118327_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25601","article-title":"Garcinone C attenuates RANKL-induced osteoclast differentiation and oxidative stress by activating Nrf2\/HO-1 and inhibiting the NF-kB signaling pathway","volume":"10","author":"Ji","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.118327_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112902","article-title":"Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-\u039ab signaling pathways","volume":"149","author":"Xu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2026.118327_b0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12896-023-00815-4","article-title":"Target identification of small molecules: an overview of the current applications in drug discovery","volume":"23","author":"Tabana","year":"2023","journal-title":"BMC Biotechnol."},{"issue":"18","key":"10.1016\/j.bcp.2026.118327_b0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149075","article-title":"MLK3 mediates impact of PKG1\u03b1 on cardiac function and controls blood pressure through separate mechanisms","volume":"6","author":"Calamaras","year":"2021","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.bcp.2026.118327_b0200","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/onc.2017.396","article-title":"MLK3 phosphorylation by ERK1\/2 is required for oxidative stress-induced invasion of colorectal cancer cells","volume":"37","author":"Schroyer","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2026.118327_b0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13659-023-00405-z","article-title":"Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress","volume":"13","author":"Ding","year":"2023","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.bcp.2026.118327_b0210","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3389\/fphar.2020.01023","article-title":"Cinnamtannin B-1 prevents ovariectomy-induced osteoporosis via attenuating osteoclastogenesis and ROS generation","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118327_b0215","article-title":"Sesamolin protects mice from ovariectomized bone loss by inhibiting osteoclastogenesis and RANKL-mediated NF-\u03baB and MAPK signaling pathways","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:17:30Z","timestamp":1788812250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":43,"alternative-id":["S0006295226006660"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118327","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2\u2032-O-Galloylhyperin attenuates osteoclastogenesis and estrogen-deficiency osteoporosis by targeting MLK3-mediated NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118327"}}